Pfizer Gets Lipitor Fraudulent Marketing Suit Tossed
A federal judge in Manhattan has thrown out a putative class action that accused Pfizer Inc. of fraudulently marketing the blockbuster cholesterol drug Lipitor by covering up certain side effects and...To view the full article, register now.
Already a subscriber? Click here to view full article